Wuhan YZY Biopharma Co Ltd

Price Chart

Risk-Adjusted Performance

Wuhan YZY Biopharma Co Ltd (2496) Price Performance

Wuhan YZY Biopharma Co Ltd (2496) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at HKD4.10, down 30.03% from the previous close.

Over the past year, 2496 has traded between a low of HKD4.10 and a high of HKD8.02. The stock has lost 7.9% over this period. It is currently 48.9% below its 52-week high.

Wuhan YZY Biopharma Co Ltd has a market capitalization of $1.20B.

About Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases. The company develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma, and other advanced solid tumors; wAMD, DME, and other ocular neovascularization-related diseases; hemophilia; and inflammatory bowel diseases. Wuhan YZY Biopharma Co., Ltd. was founded in 2010 and is headquartered in Wuhan, China.